Receptor de Canabinóides
Os receptores de canabinoides são GPCRs que mediam os efeitos dos canabinoides endógenos (endocanabinoides) e dos fitocanabinoides, como aqueles encontrados na cannabis. Os dois principais tipos de receptores de canabinoides, CB1 e CB2, estão envolvidos na regulação de uma ampla gama de processos fisiológicos, incluindo percepção da dor, apetite, humor e função imunológica. Moduladores de receptores de canabinoides têm potencial terapêutico no tratamento de condições como dor crônica, epilepsia e esclerose múltipla. Na CymitQuimica, oferecemos uma ampla gama de moduladores de receptores de canabinoides de alta qualidade para apoiar sua pesquisa em neurofarmacologia, manejo da dor e imunologia.
Foram encontrados 195 produtos de "Receptor de Canabinóides"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Rimonabant
CAS:<p>Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1.</p>Fórmula:C22H21Cl3N4OPureza:98% - 99.91%Cor e Forma:White Or Almost White Crystalline PowderPeso molecular:463.79Anandamide
CAS:<p>Anandamide ((5Z,8Z,11Z,14Z)-N-(2-Hydroxyethyl)icosa-5,8,11,14-tetraenamide), an immune modulator, acts via not only cannabinoid receptors (CB1 and CB2) but also</p>Fórmula:C22H37NO2Pureza:95.037% - 99.22%Cor e Forma:Light Yellow OilPeso molecular:347.53EHP-101
CAS:<p>EHP-101 is a PPARγ/CB2 dual agonist with anti-inflammatory properties, inhibits fat formation, and combats diet-related obesity.</p>Fórmula:C28H35NO3Pureza:98.36%Cor e Forma:SolidPeso molecular:433.58CB1 antagonist 2
CAS:<p>CB1 antagonist 2 (AM4113) is caimabinoid 1 (CB1) antagonist which inhibits CB1 in vivo with an IC50 of 25.5 nM.</p>Fórmula:C17H12Cl3N3OPureza:99.75%Cor e Forma:SolidPeso molecular:380.66Rimonabant hydrochloride
CAS:<p>Rimonabant hydrochloride (SR 141716A) 是中心大麻素受体 1 的高效选择性反向激动剂， Ki 值为1.8 nM。它也能够抑制分枝杆菌膜蛋白3。</p>Fórmula:C22H22Cl4N4OPureza:98.24% - 99.5%Cor e Forma:Off-White To White Crystalline PowderPeso molecular:500.25JHU 75528
CAS:<p>JHU 75528 (JHU-75528) is a novel PET tracer with inhibitory effects on CB that can be used to study the cannabinoid system in schizophrenic patients.</p>Fórmula:C23H21Cl2N5O2Pureza:99.79%Cor e Forma:SolidPeso molecular:470.35Pregnenolone
CAS:<p>Pregnenolone (Arthenolone) is an endogenous steroid hormone synthesized from cholesterol, used in the treatment of Alzheimer's disease.</p>Fórmula:C21H32O2Pureza:99.5% - >99.99%Cor e Forma:SolidPeso molecular:316.486-Iodopravadoline
CAS:<p>6-Iodopravadoline (AM630) is an antagonist of CB2 (Ki: 31.2 nM). And it shows 165-fold selectivity more than CB1 receptors.</p>Fórmula:C23H25IN2O3Pureza:99.29%Cor e Forma:Off-White SolidPeso molecular:504.36Vicasinabin
CAS:<p>Vicasinabin: potent CB2 agonist; researches chronic pain, atherosclerosis, bone mass, neuroinflammation.</p>Fórmula:C15H22N10OCor e Forma:SolidPeso molecular:358.41Hemopressin(rat)
CAS:<p>Peptide inhibitor for ep24.15, neurolysin & ACE with Ki 27.76, 3.43, 1.87 μM. Lowers blood pressure, modulates CB1 receptor, reduces pain & food intake.</p>Fórmula:C53H77N13O12Pureza:98%Cor e Forma:SolidPeso molecular:1088.27CB2R agonist 3
<p>CB2R agonist 3, a potent activator of cannabinoid receptor 2 (CB2R), exhibits an EC50 value of 0.37μM, indicative of its significant role in the immune system [</p>Pureza:98%Cor e Forma:Odour SolidCB2R agonist 2
<p>CB2R agonist 2 (cis-17-para) is a CB2R agonist [1].</p>Pureza:98%Cor e Forma:Odour SolidCB2 PET Radioligand 1
<p>CB2 PET Radioligand 1 (compound [18F]9) is a positron emission tomography (PET) radioligand with high affinity for the human cannabinoid receptor 2 (hCB2, Ki=7.</p>Fórmula:C20H19F3N4OPureza:98%Cor e Forma:SolidPeso molecular:388.39PSB-SB-1203
CAS:<p>PSB-SB-1203 (Compound 25b) is a dual CB1/CB2 ligand that blocks the CB1 receptor and activates the CB2 receptor with a CB1 Ki of 0.244 μM, a CB2 Ki of 0.210 μM, and an EC50 of 0.054 μM. It shows potential for research in obesity and cancer.</p>Fórmula:C25H30O4Cor e Forma:SolidPeso molecular:394.5CB2R/FAAH modulator-1
CAS:<p>CB2R/FAAH modulator-1: agonizes CB2R, inhibits FAAH (IC50=4 μM), alters cytokine production; used in inflammation research. Ki: CB2R=14.8 nM, CB1R=241.3 nM.</p>Fórmula:C24H27NO2Pureza:99.77%Cor e Forma:SoildPeso molecular:361.48Cannabidivarinic acid
CAS:<p>Cannabidivarinic acid (CBDVA), the carboxylic acid precursor to cannabidivarin (CBDV), is a non-psychoactive cannabinoid found in Cannabis and known for its anti-inflammatory properties.</p>Fórmula:C20H26O4Cor e Forma:SolidPeso molecular:330.42δ8-THC acetate
CAS:<p>Delta8-THC acetate (Delta8-tetrahydrocannabinol) is a psychoactive cannabinoid that binds to the cannabinoid receptor 1 (CB1 receptor) and exhibits anti-nausea, appetite-stimulating, and anti-inflammatory effects. It may also offer neuroprotective benefits and has potential applications in research on anxiety and depression.</p>Fórmula:C23H32O3Cor e Forma:SolidPeso molecular:356.5Δ8-THC methyl ether
CAS:<p>Δ8-THC methyl ether (compound 3) demonstrates a strong docking score of -10.167 kcal/mol for the CB2 receptor. Additionally, Δ8-THC methyl ether exhibits antinociceptive activity in mice.</p>Fórmula:C22H32O2Cor e Forma:SolidPeso molecular:328.49TRPV1/CB2 agonist 1
<p>TRPV1/CB2 agonist 1 (compound 41) is a dual agonist targeting hTRPV1 and CB2 receptors, with an EC50 value of 26.8 μM for hTRPV1. It is applicable in research related to the nervous system.</p>Cor e Forma:Odour SolidCB2 receptor agonist 9
CAS:<p>CB2 receptor agonist 9 (Compound 33) is an orally active agonist of cannabinoid receptor 2 (CB2 receptor) with an EC50 of 16.2 nM. It inhibits the expression of TNF-α, IL-1β, and IL-6, demonstrating anti-inflammatory activity in a DSS-induced acute colitis model in mice.</p>Fórmula:C16H23N3O2SCor e Forma:SolidPeso molecular:321.448β-Hydroxy-exo-THC
CAS:<p>8β-Hydroxy-exo-THC, a cannabinoid ether analog, exhibits weak affinity for receptor sites with an IC50 of 1.2 μM.</p>Fórmula:C21H30O3Cor e Forma:SolidPeso molecular:330.46(±)-9-Nor-9α-hydroxy Hexahydrocannabinol
CAS:<p>(±)-9-Nor-9α-hydroxy Hexahydrocannabinol is a cannabinoid-structured compound that exhibits potent cannabinoid-like activity in both dogs and mice.</p>Fórmula:C20H30O3Cor e Forma:SolidPeso molecular:318.45exo-Tetrahydrocannabivarin
CAS:<p>exo-Tetrahydrocannabivarin (Compound 12) is an analog of Δ9,11-THC. It weakly binds to cannabinoid receptors (CB) with an IC50 of 1.4 μM. In mice, exo-Tetrahydrocannabivarin exhibits activity related to both motor function and analgesia.</p>Fórmula:C19H26O2Cor e Forma:SolidPeso molecular:286.41Afubiata
CAS:<p>ADB-FUBIATA is a synthetic cannabinoid studied for its metabolic profile, along with AFUBIATA, CH-FUBIATA, and CH-PIATA. This in vitro analysis by Watanabe S, et al., examines these compounds, as published in "Arch Toxicol," 2023 Dec;97(12):3085-3094.</p>Fórmula:C27H29FN2OCor e Forma:SolidPeso molecular:416.53APP-FUBINACA
CAS:<p>APP-FUBINACA is a cannabinoid receptor agonist, classified as a phenylalanine amide-based indazole-3-carboxamide derivative. It exhibits neurostimulatory effects.</p>Fórmula:C24H21FN4O2Cor e Forma:SolidPeso molecular:416.45Δ8-THC-C8
CAS:<p>Δ8-THC-C8 is a semi-synthetic cannabinoid. It acts as an agonist for the cannabinoid receptor 1 (CB1) with an EC50 value of 13.8 nM.</p>Fórmula:C24H36O2Cor e Forma:SolidPeso molecular:356.54(R)-Zevaquenabant
<p>(R)-Zevaquenabant ((R)-MRI-1867) is the enantiomer of Zevaquenabant. Zevaquenabant ((S)-MRI-1867) is a peripherally restricted, orally bioavailable dual antagonist of the cannabinoid CB1 receptor and inducible nitric oxide synthase (iNOS). It is beneficial in improving chronic kidney disease (CKD) caused by obesity.</p>Cor e Forma:Odour SolidRVD-Hpα
CAS:<p>N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist.</p>Fórmula:C65H105N19O17Pureza:98%Cor e Forma:SolidPeso molecular:1424.66Zevaquenabant
CAS:<p>Zevaquenabant (S-MRI-1867): oral CB1/iNOS antagonist combatting obesity-induced CKD.</p>Fórmula:C25H21ClF3N5O2SCor e Forma:SolidPeso molecular:547.98CB2R/FAAH modulator-2
CAS:<p>CB2R/FAAH modulator-2 (compound 26) is a dual modulator targeting at CB2R and FAAH.</p>Fórmula:C24H33NO2Pureza:99.15%Cor e Forma:SoildPeso molecular:367.52CB2 receptor agonist 2
CAS:<p>CB2 receptor agonist 2 (ZINC72105556): potent, Ki=8.5 nM, high selectivity for CB2.</p>Fórmula:C30H36N2O4Pureza:99.75%Cor e Forma:SolidPeso molecular:488.62Drinabant
CAS:<p>Drinabant (AVE-1625) is an orally active CB1 receptor antagonist.</p>Fórmula:C23H20Cl2F2N2O2SPureza:99.8%Cor e Forma:SolidPeso molecular:497.38CB1R agonist 1
<p>CB1R agonist 1 (Compound '1350) is a potent full agonist of the cannabinoid-1 receptor (CB1R) with a Ki value of 0.95 nM. It demonstrates significant pain-relieving effects in various pain models, including acute thermal pain, inflammatory pain, and neuropathic pain.</p>Fórmula:C20H18F3N3O3SCor e Forma:SolidPeso molecular:437.435VIP36
<p>VIP36 is an agonist of the cannabinoid type 1 receptor (CB1) with analgesic properties. It reduces the recruitment of inhibitory proteins, thereby exerting its pain-relieving effects, and is applicable in research related to chronic pain.</p>Fórmula:C27H35FN6O4Cor e Forma:SolidPeso molecular:526.603Noladin ether
CAS:<p>Noladin ether (2-AG ether) is a cannabinoid CB1 receptor agonist.</p>Fórmula:C23H40O3Cor e Forma:SolidPeso molecular:364.56GFB-024
<p>GFB-024 is a humanized antibody targeting CB1, which can be used to study obesity.</p>Cor e Forma:LiquidPeso molecular:145.5kDaN-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide
CAS:<p>N-(1-(3,4-Dihydroxyphenyl)propan-2-yl)oleamide: binds CB1 (Ki=365 nM), activates PPARα (EC50=698 nM), reduces rat food intake, no FAAH inhibition.</p>Fórmula:C27H45NO3Cor e Forma:SolidPeso molecular:431.661Hemopressin(human, mouse) TFA
CAS:<p>Hemopressin TFA: nonapeptide from hemoglobin, oral CB1 inverse agonist, eases inflammatory pain.</p>Fórmula:C52H80F3N13O14Pureza:98%Cor e Forma:SolidPeso molecular:1168.27CB2R probe 1
CAS:<p>CB2R Probe 1, a cannabinoid 2 receptor (CB2R) fluorescent probe, exhibits both safety and environmental friendliness, boasting a dissociation constant (K i) of</p>Fórmula:C36H42N4O4Cor e Forma:SolidPeso molecular:594.74Hemopressin (human, mouse)
CAS:<p>Endogenous peptide, inhibits ep24.15/24.16/ACE with Ki of 27.76/3.43/1.87 μM. Lowers blood pressure, CB1 inverse agonist, reduces pain in vivo.</p>Fórmula:C50H79N13O12Pureza:98%Cor e Forma:SolidPeso molecular:1054.26CB1R antagonist 2
<p>CB1R antagonist 2 (Compound 11g) functions as an antagonist of the cannabinoid receptor 1 (CB1R), inhibiting the MAPK/NF-κB signaling pathway and exhibiting anti-inflammatory properties. In RAW264.7 cells, it suppresses LPS-induced expression of IL-6, IL-1β, and TNF-α. In murine models, it improves OVA-induced allergic rhinitis.</p>Fórmula:C24H26N4OCor e Forma:SolidPeso molecular:386.49CB2R/FAAH modulator-3
CAS:<p>CB2R/FAAH modulator-3 (compound 27) is a modulator targeting at CB2R and FAAH.</p>Fórmula:C22H31NO2Pureza:99.81%Cor e Forma:SoildPeso molecular:341.49Tocrifluor T1117
CAS:<p>Fluorescent form of AM 251, CB1 receptor antagonist</p>Fórmula:C56H53Cl2N7O5Pureza:98%Cor e Forma:SolidPeso molecular:974.97NESS 0327
CAS:<p>NESS 0327 is a high selectivity antagonist of the cannabinoid CB1 receptor. NESS 0327 is more than 60,000-fold selective for the CB1 receptor.</p>Fórmula:C24H23Cl3N4OPureza:99.78%Cor e Forma:SolidPeso molecular:489.82GPR55 agonist 4
<p>GPR55 agonist 4 (Compound 28), with an EC50 of 131 nM for hGPR55 and 1.41 nM for rGPR55, effectively induces β-arrestin recruitment to human GPR55 [1].</p>Fórmula:C19H16FN5O2Cor e Forma:SolidPeso molecular:365.36Taranabant racemate
CAS:<p>Taranabant racemate is an antagonist and/or inverse agonist of the Cannabinoid-1 (CB1) receptor.</p>Fórmula:C27H25ClF3N3O2Pureza:98%Cor e Forma:SolidPeso molecular:515.95Virodhamine
CAS:<p>Virodhamine (O-arachidonoyl ethanolamine), an endocannabinoid, is an antagonist of CB1 receptor and an agonist of CB2 receptor.</p>Fórmula:C22H37NO2Pureza:98%Cor e Forma:SoildPeso molecular:347.53ML-184
CAS:<p>ML-184 (CID2440433) is a potent synthetic agonist of GPR55 with EC50 of 0.26 μM.</p>Fórmula:C25H34N4O3SPureza:99.45%Cor e Forma:SolidPeso molecular:470.63JD-5037
CAS:<p>JD-5037 is a novel, peripherally restricted CB1R antagonist with an IC50 of 1.5 nM.</p>Fórmula:C27H27Cl2N5O3SPureza:99.54% - 99.84%Cor e Forma:SolidPeso molecular:572.51yangonin
CAS:<p>Yangonin (Y100550) is a novel CB1 receptor ligand with affinity for human recombinant CB1 receptors.</p>Fórmula:C15H14O4Pureza:98.82% - 99.55%Cor e Forma:Pale Yellow PowderPeso molecular:258.27N-Oleoyl glycine
CAS:<p>N-Oleoyl glycine, a lipoamino acid, was able to promote 3T3-L1 adipogenesis through the activation of CB1 receptor and the enhancement of insulin-mediated Akt</p>Fórmula:C20H37NO3Pureza:97.43%Cor e Forma:SolidPeso molecular:339.51CID 16020046
CAS:<p>CID 16020046 (C390-0219) is a selective GPR55 antagonist, inhibiting GPR55 constitutive activity with IC50 of 0.15 μM in yeast.</p>Fórmula:C25H19N3O4Pureza:99.03%Cor e Forma:SolidPeso molecular:425.44GW 405833
CAS:GW 405833 (L-768242) is an agonist of cannabinoid-2 (CB(2)) receptor-selectiveFórmula:C23H24Cl2N2O3Pureza:99.82% - 99.93%Cor e Forma:SolidPeso molecular:447.35RVD-Hpα acetate(1193362-76-3 free base)
<p>RVD-Hpα acetate is the N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist.</p>Fórmula:C67H109N19O19Pureza:99.87%Cor e Forma:SolidPeso molecular:1484.71Bay 59-3074
CAS:<p>Bay 59-3074 is a CB1/CB2 receptor partial agonist (Ki: 48.3/45.5 nM).</p>Fórmula:C18H13F6NO4SPureza:97.68% - 99.69%Cor e Forma:SolidPeso molecular:453.36Cannabigerol
CAS:Cannabigerol is a high affinity α±2-adrenergic receptor agonist, moderate affinity 5-HT1A receptor antagonist, and low affinity CB1 receptor antagonist ; alsoFórmula:C21H32O2Pureza:99.59% - 99.92%Cor e Forma:SolidPeso molecular:316.48ML-191
CAS:<p>ML-191 is an inhibitor of LPI-induced phosphorylation of ERK1/2.</p>Fórmula:C24H25N3O3Pureza:99.58%Cor e Forma:SolidPeso molecular:403.47Hemopressin (rat) acetate(568588-77-2 free base)
<p>Hemopressin is a nonapeptide, CB2 agonist, derived from rat hemoglobin, with antinociceptive properties.</p>Fórmula:C5H81N13O14Pureza:99.37%Cor e Forma:SolidPeso molecular:1148.31CB1 antagonist 4
CAS:<p>TM38837 is an antagonist of cannabinoid receptor type 1 (CB1), with potential for the treatment of obesity and type 2 diabetes.</p>Fórmula:C30H25Cl2F3N4OSPureza:98.97%Cor e Forma:SolidPeso molecular:617.51AM251
CAS:<p>AM251: potent CB1 blocker (IC50: 8 nM), 306x CB2 selective; GPR55 activator (EC50: 39 nM).</p>Fórmula:C22H21Cl2IN4OPureza:97.43% - 98.79%Cor e Forma:A Crystalline SolidPeso molecular:555.24AM281
CAS:<p>AM 281, a cannabinoid antagonist, reduces neurologic dysfunction and mortality rate after cecal ligation and puncture in rats.</p>Fórmula:C21H19Cl2IN4O2Pureza:98.6% - >99.99%Cor e Forma:White To Off-White SolidPeso molecular:557.21Linoleoyl Ethanolamide
CAS:Linoleoyl Ethanolamide is an endocannabinoid agent.Fórmula:C20H37NO2Pureza:99.97%Cor e Forma:SolidPeso molecular:323.51Otenabant
CAS:<p>Otenabant (CP-945598) has been investigated for the treatment of Obesity.</p>Fórmula:C25H25Cl2N7OPureza:99.43%Cor e Forma:SolidPeso molecular:510.42LY2828360
CAS:LY2828360: CB2 agonist, Ki=40.3 nM; biases CB2 over CB1 with EC50s of 20.1 nM and >100 μM.Fórmula:C22H27ClN6OPureza:98.45% - 99.51%Cor e Forma:SolidPeso molecular:426.94A-836339
CAS:A-836339: Potent cannabinoid, CB2-focused (Ki=0.64nM), lesser CB1 affinity (Ki=270nM); analgesic, anti-inflammatory in mice.Fórmula:C16H26N2O2SPureza:99.94%Cor e Forma:SolidPeso molecular:310.45CB1-IN-1
CAS:CB1-IN-1 (DBPR211) is a peripherally restricted CB1R antagonist, for CB1R and CB2R with Ki of 0.3 nM and 21 nM,respectively.Fórmula:C33H31Cl2F3N6O3S2Pureza:99.08% - 99.76%Cor e Forma:SolidPeso molecular:751.67BML-190
CAS:<p>BML-190 (Indomethacin morpholinylamide) 是一种 CB2 受体的配体，其对 CB2 受体 (Ki:435 nM) 和 CB1受体 (Ki> 2 μM)。</p>Fórmula:C23H23ClN2O4Pureza:97.70%Cor e Forma:SolidPeso molecular:426.89(±)-Ibipinabant
CAS:<p>(±)-Ibipinabant ((±)-SLV319) has been used in trials studying the treatment of Obesity and Obesity and Type 2 Diabetes.</p>Fórmula:C23H20Cl2N4O2SPureza:99.28% - 99.83%Cor e Forma:SolidPeso molecular:487.4ML-193
CAS:ML-193: GPR55 antagonist, IC50 221nM, 27x selective over GPR35/CB1/CB2, may aid Parkinson's symptoms.Fórmula:C28H25N5O4SPureza:97.74%Cor e Forma:SolidPeso molecular:527.59PSB-SB-487
CAS:<p>PSB-SB-487 is antagonist of GPR55.</p>Fórmula:C26H32O4Pureza:98.53%Cor e Forma:SolidPeso molecular:408.53β-Caryophyllene
CAS:<p>β-Caryophyllene ((-)-(E)-Caryophyllene) acts as an CB2 receptor agonist.</p>Fórmula:C15H24Pureza:95.43% - 99.11%Cor e Forma:Turpentine (Ntp 1992)Peso molecular:204.35Org 27569
CAS:<p>Org 27569, an allosteric modulator of cannabinoid CB1 receptor, can induce a CB1 receptor state that is characterized by decreased inverse agonist affinity and</p>Fórmula:C24H28ClN3OPureza:>99.99% - ≥95%Cor e Forma:SolidPeso molecular:409.95Olivetol
CAS:<p>Olivetol, found in lichens, is an organic antioxidant and THC synthesis precursor.</p>Fórmula:C11H16O2Pureza:99.98%Cor e Forma:(Melting Point 102-106°F) (Ntp 1992)Peso molecular:180.24Otenabant hydrochloride
CAS:<p>Otenabant hydrochloride (Otenabant) (CP-945598) is a competitive, high affinity, selective antagonist of the CB1 receptor (Ki: 0.7 nM).</p>Fórmula:C25H26Cl3N7OPureza:99.79% - ≥95%Cor e Forma:SolidPeso molecular:546.88Voacamine
CAS:<p>Voacamine: an indole alkaloid, CB1 antagonist, inhibits P-gp, may affect rhythm.</p>Fórmula:C43H52N4O5Pureza:98.54% - 99.82%Cor e Forma:SolidPeso molecular:704.9AM1241
CAS:<p>AM-1241 is a selective cannabinoid CB2 receptor agonist with Ki of 3.4 nM, exhibits 82-fold selectivity over CB1 receptor.</p>Fórmula:C22H22IN3O3Pureza:98.937% - 99.1%Cor e Forma:SolidPeso molecular:503.33Hemopressin (human, mouse) acetate
<p>Hemopressin: Nonapeptide, α1-hemoglobin derivative, CB1 inverse agonist, isolated from rats, oral, reduces inflammatory pain.</p>Fórmula:C52H83N13O14Pureza:99.86%Cor e Forma:SolidPeso molecular:1114.29GW842166X
CAS:<p>GW842166X: Potent CB2 agonist, EC50=63 nM, inactive at CB1, in Phase 2 trials.</p>Fórmula:C18H17Cl2F3N4O2Pureza:99.47%Cor e Forma:SolidPeso molecular:449.25RTICBM-189
CAS:<p>RTICBM-189 is a potent, brain-penetrant allosteric modulator of the cannabinoid type-1 (CB1) receptor with a pIC50 of 7.54 in Ca2+ mobilization assay.</p>Fórmula:C15H14Cl2N2OPureza:99.96%Cor e Forma:SolidPeso molecular:309.19Tetrahydromagnolol
CAS:<p>Tetrahydromagnolol can activate cannabinoid (CB) receptors.</p>Fórmula:C18H22O2Pureza:99.86% - >99.99%Cor e Forma:SolidPeso molecular:270.37ARN272
CAS:<p>ARN272 is a FAAH-like anandamide transporter (FLAT) inhibitor (IC50: 1.8 μM).</p>Fórmula:C27H20N4O2Pureza:98.23%Cor e Forma:SolidPeso molecular:432.47S-Methoprene
CAS:<p>S-Methoprene (ZR2458), a juvenile hormone analog, acts as an insecticide influencing redox activity and male sex differentiation.</p>Fórmula:C19H34O3Pureza:97.05% - 98.55%Cor e Forma:SolidPeso molecular:310.47CB1/2 agonist 3
CAS:<p>CB1/2 agonist 3 is a competitive and potent CB1/CB2 agonist with high affinity for hCB1 and hCB2 and can be used to study neurological disorders.</p>Fórmula:C25H41NO2Pureza:98.78%Cor e Forma:SolidPeso molecular:387.6Dehydroabiethylamine
CAS:<p>Dehydroabiethylamine (NSC-2955) boosts liver CYP2B, blocks PDKs & cholesterol transport, and has anti-tumor effects.</p>Fórmula:C20H31NPureza:98.79%Cor e Forma:Pale Yellow Viscous Liquid /Technical Grade/ Viscous Colorless To Amber LiquidPeso molecular:285.47ANEB-001
CAS:<p>ANEB-001 is an orally active CB1 inhibitor that can be used in studies of acute cannabinoid intoxication.</p>Fórmula:C22H24ClF3N2O2Cor e Forma:SolidPeso molecular:440.89CB1R Allosteric modulator 2
CAS:<p>Compound 18 is a potent CB1R allosteric modulator that acts as a negative modulator (NAM) for CB1R orthosteric ligands.</p>Fórmula:C19H15ClFN3OCor e Forma:SolidPeso molecular:355.79COR 170
CAS:<p>inverse agonist of CB2 receptors</p>Fórmula:C31H36N2O2Pureza:98%Cor e Forma:SolidPeso molecular:468.63CB1/2 agonist 2
CAS:<p>CB1/2 agonist 2 binds tightly to cannabinoid receptors, acting fully on CB1 and inversely on CB2.</p>Fórmula:C26H43NO3Cor e Forma:SolidPeso molecular:417.62LEI 101 hydrochloride
CAS:<p>LEI 101 hydrochloride is potent and selective CB2 partial agonist.</p>Fórmula:C23H26ClFN4O4SCor e Forma:SolidPeso molecular:508.99CB2R agonist 1
CAS:<p>CB2R agonist 1 selectively binds human CB2R, EC50 of 0.56 µM, modulates inflammatory cytokines.</p>Fórmula:C22H32N2OCor e Forma:SolidPeso molecular:340.5PGN36
CAS:<p>PGN36 (Compound 18) is a potent CB2 receptor antagonist with a high affinity (Ki=0.09 μM).</p>Fórmula:C21H23N3O3Cor e Forma:SolidPeso molecular:365.43CB1 inverse agonist 2
CAS:<p>CB1 inverse agonist 2, an oral drug, counters CB1 effects, reducing CP55940-induced hypothermia and anorexia in mice.</p>Fórmula:C24H20ClFN2OSCor e Forma:SolidPeso molecular:438.94CB1R Allosteric modulator 1
CAS:<p>CB1R modulator 1 (compound 11), a potent CB1R inhibitor, decreases activity of orthosteric ligands.</p>Fórmula:C24H24ClN3OCor e Forma:SolidPeso molecular:405.92S-777469
CAS:<p>S-777469: Selective CB2 agonist, oral, inhibits itching in mice (Ki: 36 nM). Anti-pruritic.</p>Fórmula:C23H27FN2O4Cor e Forma:SolidPeso molecular:414.47CB2 receptor agonist 3
CAS:<p>GP 2A is a selective agonist of CB2 receptor.</p>Fórmula:C24H23Cl2N3OCor e Forma:SolidPeso molecular:440.36GAT228
CAS:<p>GAT228, an allosteric ligand for the cannabinoid receptor 1 (CB1), functions as the enantiomer of GAT211 [1].</p>Fórmula:C22H18N2O2Cor e Forma:SolidPeso molecular:342.39O-2093
CAS:<p>anandamide uptake inhibitor</p>Fórmula:C34H43Cl2NO3Pureza:98%Cor e Forma:SolidPeso molecular:584.62CID1172084
CAS:CID1172084, a novel high-potent GPR55 agonist, interacts with cannabinoid receptors.Fórmula:C23H18FN5O2S2Cor e Forma:SolidPeso molecular:479.55COR167
CAS:<p>COR167 is a CB2 agonist with immunomodulatory effects, protective brain properties, and antinociception.</p>Fórmula:C28H38N2O2Cor e Forma:SolidPeso molecular:434.61(S)-SLV 319
CAS:<p>Ibipinabant (SLV319), a potent CB1 antagonist, K i = 7.8 nM, >1000x selective over CB2, for obesity and diabetic research.</p>Fórmula:C23H20Cl2N4O2SCor e Forma:SolidPeso molecular:487.4
